|8-K/ANov 18, 4:05 PM ET

PharmaCyte Biotech, Inc. 8-K/A

8-K/A · PharmaCyte Biotech, Inc. · Filed Nov 18, 2025

Documents

16 files
  • 8-K
  • EX-23.1

    CONSENT OF STEPHANO SLACK LLC, INDEPENDENT AUDITOR OF Q/C

  • EX-23.2

    CONSENT OF MORISON COGEN LLP, INDEPENDENT AUDITOR OF Q/C

  • EX-99.1

    Q/C AUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2024 AND 2023, AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023, TOGETHER WITH THE NOTES THERETO AND REPORTS OF INDEPENDENT AUDITORS THEREON.

  • EX-99.2

    Q/C UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2025, AND FOR THE SIX MONTHS ENDED JUNE 30, 2025, TOGETHER WITH THE NOTES THERETO.

  • EX-99.3

    UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

  • EX-101.SCH
    pmcb-20250902.xsd

    XBRL SCHEMA FILE

  • EX-101.LAB
    pmcb-20250902_lab.xml

    XBRL LABEL FILE

  • EX-101.PRE
    pmcb-20250902_pre.xml

    XBRL PRESENTATION FILE

  • XML

    IDEA: XBRL DOCUMENT

  • XML
    Show.js

    IDEA: XBRL DOCUMENT

  • XML
    report.css

    IDEA: XBRL DOCUMENT

  • XML
    FilingSummary.xml

    IDEA: XBRL DOCUMENT

  • JSON
    MetaLinks.json

    IDEA: XBRL DOCUMENT

  • ZIP
    0001683168-25-008512-xbrl.zip

    IDEA: XBRL DOCUMENT

  • XML
    pharmacyte_8ka_htm.xml

    IDEA: XBRL DOCUMENT